Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)

10 Sept 2020

Abstract excerpt

Nodal peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) remains a diagnosis encompassing a heterogenous group of PTCL cases not fitting criteria for more homogeneous subtypes. They are characterized by a poor clinical outcome when treated with anthracycline-containing regimens. A better understanding of their biology could improve prognostic stratification and foster the development of novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma Diagnosis and Treatment
Share to Sarcoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33054126
DOI: 10.3324/haematol.2020.262659

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)PMID 33054126Read ↗

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaSemantic proximity Read ↗

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profilingSemantic proximity Read ↗

Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomasSemantic proximity Read ↗

Genetic Landscape and Classification of Peripheral T Cell Lymphomas.Semantic proximity Read ↗

Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Semantic proximity Read ↗

Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targetsSemantic proximity Read ↗

New insights in the pathogenesis of T-cell lymphomasSemantic proximity Read ↗

New insights into the biology of T-cell lymphomasSemantic proximity Read ↗

Impact of <i>KMT2A</i> Rearrangement on Peripheral T‑Cell Lymphoma, Not Otherwise Specified, and Angioimmunoblastic T‑Cell LymphomaSemantic proximity Read ↗

High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays.Semantic proximity Read ↗

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.Semantic proximity Read ↗

Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.